By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS




Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





Company News
Amgen (AMGN) Completes $200 Million Biologics Facility in Singapore 11/20/2014 2:37:24 PM
Amgen (AMGN) Opens New Biomanufacturing Facility In Singapore 11/20/2014 7:20:57 AM
Amgen (AMGN) Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels 11/19/2014 11:54:13 AM
Amgen (AMGN) To Present At The Jefferies and Co. Global Healthcare Conference 11/17/2014 11:26:21 AM
Patent Fight Between Amgen (AMGN) And Sanofi (SAN.PA)/Regeneron (REGN) Getting Murkier, Says Analyst 11/13/2014 3:00:01 PM
Amgen (AMGN) To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions 11/13/2014 8:22:59 AM
Amgen (AMGN) To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab 11/13/2014 8:03:17 AM
Analyst: Amgen (AMGN)’s Psoriasis Drug Is Superior To Stelara And Sales Will Reflect That 11/12/2014 2:43:37 PM
Amgen (AMGN) And AstraZeneca PLC (AZN) Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 11/12/2014 6:08:18 AM
Amgen (AMGN) And AstraZeneca PLC (AZN)'s Psoriasis Drug Tops Johnson & Johnson (JNJ)'s Stelara In Phase 3 Study 11/12/2014 6:07:17 AM
12345678910...
//-->